NutriChem GastroGuard
Natural health product licensed in Canada
- Licence holder
- Nutri-Chem Pharmacy Ltd.
- NPN or DIN-HM
- 80070961
- Status
- Active licence
- Licence date
- 8 July 2016
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Aloe vera (L.) Burm. f.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Aloe vera Source : Gel de la feuille Extract : Matériel brut frais Dry plant equivalent : 13 Grammes | 20 milligramme | Not calculated |
| Gomme de Guar partiellement hydrolysée Source : Cyamopsis tetragonoloba | 5,000 milligramme | Not calculated |
| Gomme de Guar partiellement hydrolysée Source : Graine(s) | 5,000 milligramme | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Cuillière(s) à table | 1 Tous les jours |
Uses authorised in Canada
Source of fibre. Source of antioxidants. Used in herbal medicine as a demulcent to help soothe irritation/inflammation of the gastrointestinal tract. Helps to reduce the frequency of bowel irregularity and minor abdominal discomfort in patients with Irritable Bowel Syndrome (IBS).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
May cause mild gastrointestinal discomfort.
- Précautions et mises en garde
If symptoms persist or worsen, consult a health care practitioner. If you have diabetes, consult a health care practitioner prior to use. If symptoms worsen or if laxative effect does not occur within seven days, consult a health care practitioner. If you are taking medications which inhibit peristaltic movement, consult a health care practitioner prior to use (e.g. opioids, loperamide). If you have symptoms such as abdominal pain, nausea, vomiting or fever, consult a health care practitioner prior to use. If you are experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or have failed to defecate following the use of a laxative product, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80070961
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.